SYN

Synthetic Biologics Inc

1.02
0.00 (0.0%)

Theriva Biologics Inc Com Par $.001 (SYN) Fundamentals

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria.
SHARE INFORMATION
Market Cap$ 16,160,942
Shares Outstanding15,844,061
Float15,752,762
Percent Float99.42%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -2.14
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions61
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months519,729
Institutional Holdings Percent16.0%
Institutional Sold Previous 3 Months206,399
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months-
Insider Holdings Percent40.5
Insider Sold Previous 3 Months-
Insider Shares Owned6,418,460
TRADING INFO
52 Week High$ 4.56
52 Week Low$ 0.97
52 Week High Change$ -76.98
21 Day Moving Average$ 1.1236
21 Day Extended Moving Average$ 1.1317
50 Day Moving Average$ 1.3225
50 Day Extended Moving Average$ 1.3199
200 Day Moving Average$ 2.1452
200 Day Extended Moving Average$ 2.2104
10 Day Average Volume43,766
20 Day Average Volume48,871
30 Day Average Volume63,852
50 Day Average Volume160,389
Alpha-0.075370
Beta1.3819
Standard Deviation0.228331
R20.099584
7 Day Price Change$ -0.13
7 Day Percent Change-11.3%
21 Day Price Change$ -0.14
21 Day Percent Change-12.07%
30 Day Price Change$ -0.40
30 Day Percent Change-28.17%
Month to Date Price Change$ 0.034
Month to Date Percent Change3.45%
Quarter to Date Price Change$ 0.034
Quarter to Date Percent Change3.45%
180 Day Price Change$ -1.59
180 Day Percent Change-60.9%
200 Day Price Change$ -2.51
200 Day Percent Change-71.1%
Year to Date Price Change$ -1.70
Year to Date Percent Change-62.53%

Theriva Biologics Inc Com Par $.001 (SYN) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio4.10
Leverage Ratio1.40
Quick Ratio4.00
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-0.80
Enterprise Value$ -34,565,499
Price to Sales0.00
Price to Free Cash-0.90
PE High Last 5 Years-0.20
Price To Book0.30
Price To Cash Flow0.00
PE Low Last 5 Years-1.20
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-22.28
Return on Equity-25.73
Return on Capital-25.17

Theriva Biologics Inc Com Par $.001 (SYN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEOSteven A. Shallcross
Employees16
Last AuditUQ
CIK0000894158
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address9605 Medical Center Drive
Suite 270
Rockville, MD 20850
Websitehttps://www.syntheticbiologics.com
Facsimile+1 301 417-4367
Telephone+1 301 417-4364
Emailinfo@syntheticbiologics.com


Your Recent History
AMEX
SYN
Synthetic ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.